The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Split dose gemcitabine/ cisplatin (GC) in urothelial carcinoma of the bladder: Review of toxicity and response.
 
Laura Elizabeth Sellers
No Relationships to Disclose
 
Alex Harper
No Relationships to Disclose
 
Mark David Linch
Research Funding - Astellas Pharma (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen
 
Reena Davda
No Relationships to Disclose
 
Rowan Miller
No Relationships to Disclose
 
Heather Payne
Research Funding - Amgen; Astellas Pharma; AstraZeneca; Ipsen; Janssen; Sandoz; Sanofi; Takeda
 
Anita Mitra
No Relationships to Disclose
 
Basu Suprotim
No Relationships to Disclose
 
Zanab Wasim
No Relationships to Disclose
 
Stephen John Harland
No Relationships to Disclose
 
Ursula Brigid McGovern
No Relationships to Disclose